Photo/chemo dynamic insights into the modulation of CuSe x via Fe dopant for enhanced synergistic therapy

Authors:
Publisher website
Google Scholar
Abstract
Nanodynamic therapy integrating the merits of different dynamic therapy for maximizing the reactive oxygen species (ROS) generation serves as a highly efficient anti‐tumor strategy. Gaining dynamic insights into how nanomaterials modulate the anti‐tumor performance guides the rational design of nano‐drugs. Herein, over biocompatible CuSe x nanoparticles which have been applied in photothermal therapy, Fe species are doped for modulating the absorption profiles for ROS and bandgap of CuSe x , finally regulating the chemodynamic (CDT) and photodynamic (PDT) therapeutic performance. Experimental evidence demonstrates that Fe doped materials (FCS) endow the CuSe x with enhanced photothermal efficiency, thus thermodynamically promotes the temperature‐dependent peroxidase (POD)‐like and oxidase (OXD)‐like catalytic performance for transforming the abundant endogenous H 2 O 2 into more highly toxic ROS. In addition, the dopant of Fe species decreases the bandgap of CuSe x from 1.45 to 1.30 eV, suggesting that the PDT could be realized over FCS under the irradiation of redshifted NIR light, which is more clinically favorable. In vitro and in vivo experiments manifests that that FCS overtakes CuSe x by effectively generating ROS storms under NIR light while depleting overexpressed GSH, inducing tumor cell death through dual pathways. This work offers a novel perspective for the design of smart‐responsive nanomedicine.
Funding Information
  • China Postdoctoral Science Foundation (2024M752127)
  • China Postdoctoral Science Foundation (HTHZQSWS‐KCCYB‐2023060)
  • National Natural Science Foundation of China (52203335)
  • National Natural Science Foundation of China (82192865)
  • National Natural Science Foundation of China (82403420)
  • Sanming Project of Medicine in Shenzen Municipality (SZSM202111016)
  • Sanming Project of Medicine in Shenzen Municipality (SZSM202211022)
  • Shenzhen Clinical Medical Research Center for Otolaryngology Diseases (20220819120540004)
  • China Postdoctoral Science Foundation (2024M752127)
  • China Postdoctoral Science Foundation (HTHZQSWS-KCCYB-2023060)
  • National Natural Science Foundation of China (52203335)
  • National Natural Science Foundation of China (82192865)
  • National Natural Science Foundation of China (82403420)
  • Shenzhen Science and Technology Innovation Committee (JCYJ20210324103203010)
  • Shenzhen Science and Technology Innovation Committee (JCYJ20240813115805008)
  • Shenzhen Science and Technology Innovation Committee (ZDSYS201707281114196)
  • Sanming Project of Medicine in Shenzen Municipality (SZSM202111016)
  • Sanming Project of Medicine in Shenzen Municipality (SZSM202211022)

This publication has 58 references indexed in Scilit: